[罕见的肺癌亚型]
Audrey Mansuet-Lupo1, Diane Damotte1
1Service d'anatomie pathologique, hôpital Cochin, AP-HP Centre, université Paris Cité, Paris, France.
Bulletin du cancer
|March 28, 2025
概括
罕见的肺癌,定义为不到6/100,000的发病率,需要专门的护理. 分子表征有助于识别和管理这些多样化的胸部瘤.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 病理学 病理学 病理学
背景情况:
- 在欧洲,罕见的肺癌被定义为发生率低于6/100,000的肺癌.
- 这些癌症约占所有肺癌的10%,包括各种组织学类型,如癌瘤,肉瘤和淋巴瘤.
- 管理需要在诊断,治疗和随访方面拥有专业的专业知识,强调向专家中心转介.
研究的目的:
- 审查罕见胸部瘤的分类和管理.
- 突出分子表征在识别特定罕见肺癌实体中的重要性.
- 讨论为患有罕见肺癌的患者提供专业护理途径和获得创新治疗的必要性.
主要方法:
- 审查2021年世卫组织胸部瘤分类.
- 分析在欧洲定义罕见癌症的发病率.
- 讨论分子表征在罕见瘤识别中的作用.
主要成果:
- 罕见的肺癌包括许多具有不同起源的组织学实体.
- 系统的分子表征有助于识别和更好地了解特定的罕见肺瘤实体.
- 一些罕见的肺瘤实体只存在于肺部,而其他实体也存在于不同的器官中.
结论:
- 患有罕见肺癌的患者受益于在国家网络内的专家中心的转诊,以获得最佳的护理.
- 通过专门的中心和网络,改善了获得创新治疗的机会.
- 分子分析对于精确的诊断和针对罕见胸部恶性瘤的量身定制的治疗策略至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.


